 |
|
OHSU Cancer Institute, VA researchers find way to identify which men need a second biopsy
June 04, 2007PORTLAND, Ore. - A researcher in the Oregon Health & Science University Cancer Institute and Portland Veterans Affairs Medical Center has found a way to identify which men need a second prostate biopsy because they may be harboring life-threatening prostate cancer even though they were given a clean bill of health after their first biopsy.
Shane Rogosin, M.D., principal investigator, resident, in general internal medicine, OHSU School of Medicine, will present the research on Saturday, June 2 at 1:45 p.m. CDT at the 43rd annual meeting of the American Society of Clinical Oncologists in Chicago.
Also involved in the research is Mark Garzotto, M.D., h the director of urologic oncology at the Portland Veterans Affairs Medical Center, assistant professor of surgery (urology) in the OHSU School of Medicine, and member of the OHSU Cancer Institute.
"Until now we've really had no clear and consistent method to recommend further follow up or diagnostic procedures for men who have a negative biopsy. We have derived a simple marker so urologists can identify who is at risk for high-grade prostate cancer," Garzotto said.
Rogosin studied what is considered a large group, 511 subjects at the Portland Veterans Affairs Medical Center from 1992 to 2006. All had been referred to urology clinics for suspicion of prostate cancer. All patients had one prior negative prostate biopsy. In all, the study included 1,319 biopsies.
What the researchers found to be the indicator for a repeat biopsy was a high prostate specific antigen (PSA) adjusted for prostate size. A Gleason score of 7 or above was indicative that life-threatening prostate cancer may be present and a repeat biopsy is advised.
A Gleason score is a system of grading prostate cancer tissue based on how it looks under a microscope. Gleason scores range from 2 to 10 and indicate how likely it is that a tumor will spread. A low Gleason score means the cancer tissue is similar to normal prostate tissue and the cancer is less likely to spread; a high Gleason score means the cancer tissue is very different from normal tissue and the tumor is more likely to spread. A high grade of cancer results in a higher PSA. Garzotto also stresses the size of the prostate has to be taken into account when measuring PSA.
"What we worry about is which men may have high-grade cancer. Now we can prescribe a second biopsy for a few months later. We know that this is a judicious use for a biopsy," Garzotto said. Besides identifying which men may have a deadly form of prostate cancer this new finding could also reduce the rate of overtreatment, unnecessary biopsies and overdiagnosis.
Prostate biopsies can cause patient anxiety, pain, bleeding and infection, and can lead to a significant increase in medical and non-medical costs to health care systems and patients.
This study is particularly meaningful because of the large sample size of patient cases, and it is longitudinal, which means researchers were able to study the patients for many years.
Oregon Health & Science University
"Until now we've really had no clear and consistent method to recommend further follow up or diagnostic procedures for men who have a negative biopsy. We have derived a simple marker so urologists can identify who is at risk for high-grade prostate cancer," Garzotto said.
Rogosin studied what is considered a large group, 511 subjects at the Portland Veterans Affairs Medical Center from 1992 to 2006. All had been referred to urology clinics for suspicion of prostate cancer. All patients had one prior negative prostate biopsy. In all, the study included 1,319 biopsies.
What the researchers found to be the indicator for a repeat biopsy was a high prostate specific antigen (PSA) adjusted for prostate size. A Gleason score of 7 or above was indicative that life-threatening prostate cancer may be present and a repeat biopsy is advised.
A Gleason score is a system of grading prostate cancer tissue based on how it looks under a microscope. Gleason scores range from 2 to 10 and indicate how likely it is that a tumor will spread. A low Gleason score means the cancer tissue is similar to normal prostate tissue and the cancer is less likely to spread; a high Gleason score means the cancer tissue is very different from normal tissue and the tumor is more likely to spread. A high grade of cancer results in a higher PSA. Garzotto also stresses the size of the prostate has to be taken into account when measuring PSA.
"What we worry about is which men may have high-grade cancer. Now we can prescribe a second biopsy for a few months later. We know that this is a judicious use for a biopsy," Garzotto said. Besides identifying which men may have a deadly form of prostate cancer this new finding could also reduce the rate of overtreatment, unnecessary biopsies and overdiagnosis.
Prostate biopsies can cause patient anxiety, pain, bleeding and infection, and can lead to a significant increase in medical and non-medical costs to health care systems and patients.
This study is particularly meaningful because of the large sample size of patient cases, and it is longitudinal, which means researchers were able to study the patients for many years.
Oregon Health & Science University
Biopsy Current Events and Biopsy News RSSElastography reduces unnecessary breast biopsies
Elastography is an effective, convenient technique that, when added to breast ultrasound, helps distinguish cancerous breast lesions from benign results, according to an ongoing study presented today at the annual meeting of the Radiological Society of North America (RSNA).
Engineer designs micro-endoscope to seek out early signs of cancer
Traditional endoscopes provide a peek inside patients' bodies. Now, a University of Florida engineering researcher is designing ones capable of a full inspection.
UCLA researchers create 'fly paper' to capture circulating cancer cells
Just as fly paper captures insects, an innovative new device with nano-sized features developed by researchers at UCLA is able to grab cancer cells in the blood that have broken off from a tumor.
Barrow study identifies new way to biopsy brain tumors in real time
A new miniature, hand-held microscope may allow more precise removal of brain tumors and an easier recognition of tumor locations during surgery.
Routine evaluation of prostate size not as effective in cancer screening, Mayo study finds
New Mayo Clinic research studied the association between prostate-specific antigen (PSA) levels and prostate size and found that routine annual evaluation of prostate growth is not necessarily a predictor for the development of prostate cancer.
For young boys with cancer, testicular tissue banking may be option to preserve fertility
For parents of children with cancer, the hopeful news is that pediatric survival rates have steadily improved for decades. Among the bad news-treatments that enable survival often cause infertility.
Mount Sinai finds those with more difficult to treat forms of HCV are half as likely to get treated
A new study by Mount Sinai researchers has for the first time found that patients with more difficult to treat forms of hepatitis C are half as likely to initiate treatment for the disease, when compared to patients with hepatitis C that is easier to treat.
Hundreds of genes distinguish patients likely to survive advanced melanoma
Although the chances of surviving advanced melanoma aren't very good with current therapies, some patients can live for years with cancer that has spread beyond the skin to other organs.
New finding suggests prostate biopsy is not always necessary
Researchers at Wake Forest University School of Medicine and the University of Wisconsin-Madison have discovered that some elevated prostate-specific antigen (PSA) levels in men may be caused by a hormone normally occurring in the body, and are not necessarily a predictor of the need for a prostate biopsy.
Does prostate-specific antigen velocity help in early detection prostate cancer?
The November issue of European Urology, the official journal of the European Association of Urology, features an article focussing on prostate specific antigen (PSA) velocity and early cancer detection. It has been suggested that changes in PSA over time aid prostate cancer detection.
More Biopsy Current Events and Biopsy News Articles
 |
Biopsy Interpretation: The Frozen Section (Biopsy Interpretation Series) by Jerome B Taxy (Author), Aliya N Husain (Author), Anthony G Montag (Author) A frozen section is regarded as the most definitive intraoperative examination, and its proper performance and interpretation is essential to determine the course of a given surgical procedure. Put simply, a frozen section involves a freezing apparatus to harden tissue, a microtome to shave off thin slices, an H&E staining set-up, and a microscope, and it requires an expert pathologist to interpret and communicate the results. This new volume of the Biopsy Interpretation Series is a practical, superbly illustrated guide to the technical and interpretive aspects of a frozen section. The book gives pathologists a thorough knowledge of the utility and limitations of a frozen section, the appropriate circumstances for doing one, the proper techniques, and the interpretation and reporting of... |
 |
Diagnosis of Endometrial Biopsies and Curettings: A Practical Approach by Michael Mazur (Author), Robert J. Kurman (Author) DIAGNOSIS OF ENDOMETRIAL BIOPSIES, Second Edition, revised and now with color illustrations, continues the tradition as being the most concise and complete diagnostic guide to the endometrial biopsy. A review from MODERN PATHOLOGY praises it as being "extremely useful for the practicing pathologist because it outlines criteria for diagnosis, helps in solving diagnostic diagnostic dilemmas, and clarifies controversial issues." The text is structured to present a logical approach to formulating a pathologic diagnosis from the diverse array of tissue received in the surgical pathology laboratory. Color illustrations show typical artifacts and distortion and explain their impact on diagnostic interpretation. Each chapter includes a section on "Clinical Queries and Reporting" that... |
 |
Biopsy Interpretation of the Breast (Biopsy Interpretation Series) by Stuart J Schnitt (Author), Laura C Collins (Author) A practical guide for the diagnostic surgical pathologist, this book presents the diverse spectrum of pathologic alterations that occur in the breast in a manner analogous to the way they are encountered in daily practice. Lesions are grouped according to their histologic patterns to simulate the way pathologists face these lesions as they examine microscopic slides. The approach is based on pattern recognition and emphasizes differential diagnosis. The book contains over 500 full-color photomicrographs and 50 tables summarizing key clinical and pathologic features and differential diagnostic issues. A companion Website will offer 900 full-color images, plus the fully searchable text and a test bank that is ideal for board preparation. |
 |
Biopsy Interpretation of the Thyroid (Biopsy Interpretation Series) by Scott L Boerner (Author), Sylvia L Asa (Author) Thyroid and parathyroid are easily accessible and common sites of palpable nodules; in this era of ultrasound, nodules in these tissues are being detected at an increasing rate and it is now estimated that up to 70% of the population in North America has an ultrasound-detectable thyroid nodule. The procedure of choice to triage patients for surgery or surveillance is the needle biopsy. Since thyroid cancer is one of the few malignancies that is showing an increase in incidence, it is imperative that Pathologists know the approach to the interpretation of biopsies. Moreover, the correct diagnosis of these lesions will lead to more appropriate surgical intervention and prevent repeat surgeries. At the mement, many patients undergo emithyroidectomy based on inconclusive pre-operative... |
 |
Biopsy Punch, Sterile, Assorted Box of 2, 3 ,4, 5, 6mm, 25/Bx by FRAY Features of the Biopsy Punch: Seamless sharp blade. Hollow handle. Safety capped. Sterile, single use disposable. Sterility indicator dot gives visual evidence of sterility. Tamper evident seal. Gamma Sterilized (cell and tissue cultures suffer adverse effects or sometimes are destroyed when exposed to EtO residues). Sure Grip handle. Color coded handle embossed with size. Easy to peel "no fiber tear" pouch. Dispenser Box: 5 each of sizes 2, 3, 4, 5 and 6mm. The product referenced on this detail page is sold be 25/box. |
 |
Biopsy Interpretation of the Prostate (Biopsy Interpretation Series) by Jonathan I Epstein (Author), George J Netto (Author) The revised Fourth Edition of this highly acclaimed reference is a practical, state-of-the-art, superbly illustrated guide to the evaluation and clinical correlates of prostate biopsy findings. This edition features expanded coverage of mimickers of prostate cancer, a new chapter on immunohistochemistry and molecular techniques, a major update to the Gleason grading system, new information on histologic changes following radiation therapy, and an expanded section on tumors of specialized prostatic stroma. The book contains nearly 300 full-color illustrations. A companion online image bank provides over 1,800 full-color images of specimens at various magnifications, plus a question-and-answer review of prostate pathology. "Doody's Core TitlesTM 2009." |
 |
Third Stroke Biopsy (Performer) THE THIRD AND MOST ELECTRO ALBUM OF THIS DUO (FABRICIO VISCARDI + GUILHERME PIRES), MEMBERS OF AGHAST VIEW IS OUT NOW WITH 14 TRAXX TO PUNCH AND TERMINATE. A HARSH BLEND OF EBM WITH NOISE AND BEATS THAT WILL PLEASE THE RIVET HEADS TO THEIR CORE. |
 |
Miltex Softflex Endometrial Biopsy Cannula by MILTEX Miltex SoftFlex Endometrial Biopsy Cannula : Sterile, single-use. |
 |
Third Stroke Biopsy (Primary Contributor) |
 |
Biopsy Interpretation of the Skin: Primary Non-Lymphoid Neoplasms of the Skin (Biopsy Interpretation Series) by A. Neil Crowson (Author), Cynthia M Magro (Author), Martin C Mihm (Author) This new volume of the Biopsy Interpretation Series is a practical, superbly illustrated reference on the primary non-lymphoid neoplasms of the skin. The book offers guidelines on how and when to biopsy the skin and then discusses benign melanocytic proliferations, precursor lesions to melanoma, and melanomas. Also included are discussions of basal cell carcinoma, squamous cell carcinoma and its precursors, benign and malignant adnexal neoplasms, and soft tissue neoplasms of the skin and superficial subcutis. A major highlight of the book is the extensive discussion of differential diagnostic considerations and their separation from the main diagnostic entities under consideration. The book features nearly 300 full-color images. A companion Website will provide 400 additional figures,... |
| © 2009 BrightSurf.com |